UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043225
Receipt number R000049328
Scientific Title Elucidation of metabolic and immune programing by placenta and prenatal exposure to maternal gut environmental factors
Date of disclosure of the study information 2021/02/02
Last modified on 2023/03/16 14:33:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of metabolic and immune programing by placenta and prenatal exposure to maternal gut environmental factors

Acronym

Elucidation of metabolic and immune programing by placenta and prenatal exposure to maternal gut environmental factors

Scientific Title

Elucidation of metabolic and immune programing by placenta and prenatal exposure to maternal gut environmental factors

Scientific Title:Acronym

Elucidation of metabolic and immune programing by placenta and prenatal exposure to maternal gut environmental factors

Region

Japan


Condition

Condition

pregnant woman and newborn baby

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Elucidation of metabolic imprinting and immune system of uterus influenced by maternal gut microbiota

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Elucidation of the role of maternal gut microbiota that influence maternal and infant condition and immune system of uterus

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

pregnant woman scheduled cesarean section

Key exclusion criteria

under 20 years old

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name ITOH

Organization

Hamamatsu University school of medicine

Division name

obstetrics and gynecology

Zip code

431-3192

Address

1-20-1 Higashi-ku Handayama, Hamamatsu-city

TEL

0534352309

Email

hitou-endo@umin.ac.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name ITOH

Organization

Hamamatsu University school of medicine

Division name

obstetrics and gynecology

Zip code

431-3192

Address

1-20-1 Higashi-ku Handayama, Hamamatsu-city

TEL

0534352309

Homepage URL


Email

hitou-endo@umin.ac.jp


Sponsor or person

Institute

Hamamatsu University school of medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hamamatsu University school of medicine

Address

1-20-1 Higashi-ku Handayama, Hamamatsu-city

Tel

0534352309

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 02 Month 02 Day

Date of IRB


Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Literature search is to be done on 31/3/2021.
Statistical analyses is to be done by 3/31/2026.


Management information

Registered date

2021 Year 02 Month 02 Day

Last modified on

2023 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049328


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name